Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4093784

O=C(O)C(F)(F)F.O=C1N=C(Nc2cc(NC(=O)N3CCCCC3)ccc2Cl)SC1=Cc1ccc2ncccc2c1

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 2/20 0.42
DYRK3 O43781 2/20 0.39
RAB9A P51151 6/20 0.38
KDM4E B2RXH2 4/20 0.38
NPC1 O15118 3/20 0.38
HSD17B10 Q99714 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
TP53 P04637 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
ALDH1A1 P00352 2/20 0.37
MAPT P10636 2/20 0.37
THRB P10828 1/20 0.37
PIK3CD O00329 1/20 0.37
PIM1 P11309 1/20 0.37
CSNK2A2 P19784 1/20 0.37
PIK3CA P42336 1/20 0.37
PIK3CG P48736 1/20 0.37
CLK1 P49759 1/20 0.37
CLK3 P49761 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4093780 1.00 TRPV1 (0.42) TRPV1DYRK3RAB9AKDM4ENPC1
SCHEMBL2993432 0.95 DYRK3 (0.42) TRPV1DYRK3RAB9AKDM4ENPC1
SCHEMBL2993435 0.95 DYRK3 (0.42) TRPV1DYRK3RAB9AKDM4ENPC1
Trifluoroacetic Acid SCHEMBL4091117 0.90 OGA (0.39) DYRK3TP53ALDH1A1MAPTGAA
Trifluoroacetic Acid SCHEMBL4091128 0.90 OGA (0.39) DYRK3TP53ALDH1A1MAPTGAA
Trifluoroacetic Acid SCHEMBL4093888 0.89 OGA (0.40) DYRK3TP53ALDH1A1MAPTPIK3CD
Trifluoroacetic Acid SCHEMBL4093894 0.89 OGA (0.40) DYRK3TP53ALDH1A1MAPTPIK3CD
Trifluoroacetic Acid SCHEMBL4095087 0.86 PABPC1 (0.48) DYRK3RAB9ANPC1SMN1; SMN2ALDH1A1
Trifluoroacetic Acid SCHEMBL4095081 0.86 PABPC1 (0.48) DYRK3RAB9ANPC1SMN1; SMN2ALDH1A1
Trifluoroacetic Acid SCHEMBL4089999 0.86 DYRK3 (0.38) DYRK3RAB9ANPC1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090203692-A1 NOVEL CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION 2009-08-13 US disclosed
EP-1885362-A2 NOVEL CHEMICAL COMPOUNDS Smithkline Beecham Corporation (US) 2008-02-13 EP disclosed
WO-2006127458-A2 NOVEL CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2006-11-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203692-A1 NOVEL CHEMICAL COMPOUNDS HIPK3, HIPK1, HIPK4 TRPV1 4429/4885DYRK3 1471/4885RAB9A 1181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.